Please login to the form below

Not currently logged in
Email:
Password:

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

Choices, choices: the rapidly evolving HIV treatment landscape

Doctor writing prescription for medicinesThe treatment options for HIV in Europe has seen some revolutionary changes

Russian innovation at the crossroads

Despite improvements, investors face rising risks

Deal Watch table for January 2015

Deal Watch tableTable listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during January 2015

deal watch image mergers acquisitions pharmaDeal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Webinars

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Digital: Fallacy or the Future Face of Pharma Marketing?

Digital: Fallacy or the Future Face of Pharma MarketingReach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust,

UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

Video

The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

Capturing "in-the-moment" patient and physician insights

Utilising the benefits of mobile technology

Webinar: Observational Research

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What's inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, market access, healthcare digital excellence, and strategic consultancy. We bring...